Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice
Top Cited Papers
Open Access
- 22 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (5), 1-17
- https://doi.org/10.1038/s41419-020-2544-7
Abstract
Inhibition of sodium–glucose cotransporter 2 (SGLT2) in the proximal tubule of the kidney has emerged as an effective antihyperglycemic treatment. The potential protective role of SGLT2 inhibition on diabetic kidney disease (DKD) and underlying mechanism, however, remains unknown. In this study, metabolic switch was examined using kidney samples from human with diabetes and streptozocin (STZ)-induced experimental mouse model of diabetes treated with or without SGLT2 inhibitor dapagliflozin. Results were further validated using primarily cultured proximal tubule epithelial cells. We found that DKD development and progression to renal fibrosis entailed profound changes in proximal tubule metabolism, characterized by a switch from fatty acid utilization to glycolysis and lipid accumulation, which is associated with the increased expression of HIF-1α. Diabetes-induced tubulointerstitial damage, such as macrophage infiltration and fibrosis, was significantly improved by dapagliflozin. Consistent with the effects of these beneficial interventions, the metabolic disorder was almost completely eliminated by dapagliflozin. The increased level of HIF-1α in renal proximal tubule was nearly nullified by dapagliflozin. Moreover, dapagliflozin protects against glucose-induced metabolic shift in PTCs via inhibiting HIF-1α. It suggests that SGLT2 inhibition is efficient in rectifying the metabolic disorder and may be a novel prevention and treatment strategy for kidney tubule in DKD.Keywords
Funding Information
- National Natural Science Foundation of China (81530022, 81873618, 81600526)
This publication has 58 references indexed in Scilit:
- Mortality Rates in Trials of Subjects With Type 2 DiabetesJournal of the American Heart Association, 2012
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- The proximal tubule in the pathophysiology of the diabetic kidneyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditureThe American Journal of Clinical Nutrition, 2010
- Activation of a HIF1α-PPARγ Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac HypertrophyCell Metabolism, 2009
- Glucose Control by the Kidney: An Emerging Target in DiabetesAmerican Journal of Kidney Diseases, 2009
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- A primary culture of mouse proximal tubular cells, established on collagen-coated membranesAmerican Journal of Physiology-Renal Physiology, 2007
- Structural-functional relationships in diabetic nephropathy.JCI Insight, 1984
- Sodium Transport and Oxygen Consumption in the Mammalian KidneyNature, 1961